Korro Bio, Inc.
NASDAQ:KRRO · NASDAQ Capital Market
+$1.76 today
Vol 0.73M · Avg 0.15M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+10.55%
Period High
$51.36
Period Low
$5.28
Latest
$12.99
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$854.13M
Alto Neuroscience, Inc.
NYSE:ANRO
$787.86M
Annexon, Inc.
NASDAQ:ANNX
$586.92M
Aura Biosciences, Inc.
NASDAQ:AURA
$396.75M
DBV Technologies S.A.
NASDAQ:DBVT
$382.85M
Amarin Corporation plc
NASDAQ:AMRN
$334.13M
Silence Therapeutics plc
NASDAQ:SLN
$321.19M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$305.09M
Altimmune, Inc.
NASDAQ:ALT
$240.50M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest KRRO filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does KRRO have?
Intrinsic Alpha currently shows 20 recent filings for KRRO.
Explore More
Continue the stock analysis
Jump to another research area for this company.